Statistiche di base
| CIK | 797542 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Viewbix Inc.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact N |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| August 5, 2025 |
Exhibit 4.2 VIEWBIX INC. TO [], as Trustee GUARANTEED TO THE EXTENT SET FORTH HEREIN BY THE GUARANTORS NAMED HEREIN INDENTURE Dated as of [], 20[] SENIOR DEBT SECURITIES TABLE OF CONTENTS Page Article One Definitions and Other Provisions of General Application 1 Section 101 Definitions 1 Section 102 Compliance Certificates and Opinions 8 Section 103 Form of Documents Delivered to Trustee 8 Section |
|
| August 5, 2025 |
Exhibit 4.3 VIEWBIX INC. TO [], as Trustee GUARANTEED TO THE EXTENT SET FORTH HEREIN BY THE GUARANTORS NAMED HEREIN INDENTURE Dated as of [], 20[] SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page Article One Definitions and Other Provisions of General Application 1 Section 101 Definitions 1 Section 102 Compliance Certificates and Opinions 9 Section 103 Form of Documents Delivered to Trustee 9 S |
|
| August 5, 2025 |
As filed with the Securities and Exchange Commission on August 5, 2025 As filed with the Securities and Exchange Commission on August 5, 2025 Registration No. |
|
| August 5, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Pr |
|
| July 31, 2025 |
1,851,846 Shares of Common Stock Viewbix Inc. PROSPECTUS Filed pursuant to Rule 424(b)(3) Registration No. 333-288886 1,851,846 Shares of Common Stock Viewbix Inc. This prospectus relates to the resale, from time to time, by the selling stockholders identified in this prospectus, or the selling stockholders, of up to 1,851,846 shares of our common stock, par value $0.0001 per share, consisting of (i) 848,763 shares of our common stock issued |
|
| July 23, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Viewbix Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(4) Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| July 23, 2025 |
As filed with the Securities and Exchange Commission on July 23, 2025 As filed with the Securities and Exchange Commission on July 23, 2025 Registration No. |
|
| July 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 22, 2025 (July 16, 2025) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 001-42681 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| July 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 11, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 001-42681 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identifi |
|
| July 14, 2025 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| July 14, 2025 |
Form of Registration Rights Agreement Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 11, 2025, by and between Viewbix Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Purchase Agr |
|
| July 14, 2025 |
Form of Placement Agent Agreement Exhibit 10.5 July 11, 2025 PERSONAL AND CONFIDENTIAL Mr. Amihay Hadad, Chief Executive Officer Viewbix Inc. 3 Hanehoshet St, Building B, 7th floor Tel Aviv, Israel 6971068 Re: VBIX | PIPE Offering | Placement Agent Agreement Dear Mr. Hadad: The purpose of this Placement Agent Agreement is to outline our agreement pursuant to which Aegis Capital Corp. (“Aegis”) will act as the placement agent on a |
|
| July 14, 2025 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| July 14, 2025 |
Form of Securities Purchase Agreement Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 11, 2025, between Viewbix Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set forth |
|
| June 25, 2025 |
Viewbix Inc. 11 Derech Menachem Begin Street Ramat Gan, Israel Viewbix Inc. 11 Derech Menachem Begin Street Ramat Gan, Israel June 25, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Viewbix Inc. (CIK 0000797542) Registration Statement No. 333-288164 on Form S-1 (the “Registration Statement”) Ladies and Gentlemen: Viewbix Inc. hereby requests acceleration of the effectiveness of the |
|
| June 20, 2025 |
As filed with the Securities and Exchange Commission on June 20, 2025 As filed with the Securities and Exchange Commission on June 20, 2025 Registration No. |
|
| June 20, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Viewbix Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(4) Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| June 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 10, 2025 (June 9, 2025) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 001-42681 Delaware 68-0080601 (State of Incorporation) (I.R.S. Em |
|
| June 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 9, 2025 (March 23, 2025) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-42681 Delaware 68-0080601 (State of Incorporation) (I.R.S. |
|
| June 9, 2025 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On March 24, 2025 (the “Closing Date”), the Viewbix. Inc. (the “Company” or “Viewbix”) entered into a securities exchange agreement (the “Agreement”) with Metagramm Software Ltd., an Israeli company (“Metagramm”), and all of the shareholders of Metagramm (the “Metagramm Shareholders”). Pursuant to the Agreement, the Company |
|
| June 9, 2025 |
METAGRAMM SOFTWARE LTD. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2024 Exhibit 99.2 METAGRAMM SOFTWARE LTD. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2024 CONTENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheet F-3 Consolidated Statement of Operations F-5 Consolidated Statement of Changes in Shareholders’ Equity (Deficiency) F-6 Consolidated Statement of Cash Flows F-7 Notes to Consolidated Financial Statement F-8 F-1 |
|
| June 4, 2025 |
Viewbix Announces Uplist to Nasdaq Exhibit 99.1 Viewbix Announces Uplist to Nasdaq Tel Aviv, Israel, June 4, 2025 – Viewbix Inc. (OTC: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies, today announced that its shares of common stock were approved for listing on the Nasdaq Capital Market (“Nasdaq”). The Company expects that its shares of common stock will begin trading on the Nasdaq under the |
|
| June 4, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 4, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identific |
|
| June 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF l934 VIEWBIX INC. (Exact name of Registrant as specified in its charter) Delaware 68-0080601 (State of incorporation or organization) (I.R.S. Employer Identification No.) 3 Hanehoshet St, Building B, 7t |
|
| June 3, 2025 |
Viewbix Inc. 11 Derech Menachem Begin Street Ramat Gan, Israel Viewbix Inc. 11 Derech Menachem Begin Street Ramat Gan, Israel June 3, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Viewbix Inc. (CIK 0000797542) Registration Statement No. 333-281143 on Form S-1 (the “Registration Statement”) Ladies and Gentlemen: Viewbix Inc. hereby requests acceleration of the effectiveness of the |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 27, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identif |
|
| March 24, 2025 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Emerald Medical Applications Ltd.(2) Israel VB Interactive Video Technologies Inc.(3) Delaware Gix Media Ltd.(4) Israel Cortex Media Group Ltd. (5) Israel Metagramm Software Ltd. (6) Israel (1) Viewbix Ltd. is a wholly-owned subsidiary of Viewbix Inc. (2) Emerald Medical Applications Ltd. is a wholl |
|
| March 24, 2025 |
Exhibit 10.1 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (the “Agreement”) is entered into as of March 24, 2025 (the “Effective Date”), by and between: Metagramm Software Ltd. a private company limited by shares incorporated in Israel (the “Company”); and The shareholders of the Company, listed on Schedule 1 attached hereto (the “MS Shareholders”); and Viewbix, Inc., a publicl |
|
| March 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 23, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identif |
|
| March 24, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Viewbix Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(4) Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| March 24, 2025 |
As filed with the Securities and Exchange Commission on March 24, 2025 As filed with the Securities and Exchange Commission on March 24, 2025 Registration No. |
|
| March 21, 2025 |
Executive Officer Clawback Policy Exhibit 97.1 Viewbix Inc. Executive Officer Clawback Policy I. Purpose This Executive Officer Clawback Policy describes the circumstances under which Covered Persons of Viewbix Inc. and any of its direct or indirect subsidiaries (the “Company”) will be required to repay or return Erroneously-Awarded Compensation to the Company. This Policy and any terms used in this Policy shall be construed in ac |
|
| March 21, 2025 |
Insider Trading Compliance Policy Exhibit 19.1 VIEWBIX INC. Insider Trading Compliance Policy Adopted March 19, 2025 Contents Page I. Introduction and Persons Covered by this Policy 1 II. Statement of Policies Prohibiting Insider Trading 2 III. Explanation of Insider Trading 2 IV. Procedures to Prevent Insider Trading 5 V. Additional Prohibited Transactions 7 VI. Rule 10b5-1 Trading Plans 9 VII. Interpretation, Amendment, and Impl |
|
| March 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its C |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 12, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identif |
|
| February 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 2, 2025 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ident |
|
| January 21, 2025 |
January 21, 2025 Securities and Exchange Commission Division of Corporate Finance 100 F Street, N. |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Rep |
|
| November 6, 2024 |
VBIX / Viewbix Inc. / MMCAP International Inc. SPC - FORM SC 13G/A Passive Investment SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) Viewbix Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 926711201 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of This Statement) Check the Appropriate bo |
|
| September 18, 2024 |
VBIX / Viewbix Inc. / M.R.M Merhavit Holding & Management Ltd Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Viewbix Inc. |
|
| September 18, 2024 |
VBIX / Viewbix Inc. / Capitalink Ltd. Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Viewbix Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 926711201 (CUSIP Number) July 4, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which |
|
| September 18, 2024 |
Joint Filing Agreement, dated as of September 18, 2024, by and between the Reporting Persons. EX-99.1 2 ex99-1.htm Exhibit 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledge and agree, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly o |
|
| September 18, 2024 |
Joint Filing Agreement, dated as of September 18, 2024, by and between the Reporting Persons. EX-99.1 2 ex99-1.htm Exhibit 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledge and agree, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly o |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 13, 2024 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ide |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact N |
|
| August 1, 2024 |
Viewbix Inc. 3 Hanehoshet St, Building B, 7th Floor Tel Aviv, Israel 6971068 Viewbix Inc. 3 Hanehoshet St, Building B, 7th Floor Tel Aviv, Israel 6971068 August 1, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Matthew Derby Re: Viewbix Inc. Registration Statement on Form S-1 Filed July 31, 2024 File No. 333-281143 Dear Mr. Derby: Viewbix Inc. hereby amends the Registration Statement on F |
|
| July 31, 2024 |
As filed with the Securities and Exchange Commission on July 31, 2024 As filed with the Securities and Exchange Commission on July 31, 2024 Registration No. |
|
| July 31, 2024 |
Exhibit 10.1 AMENDED AND RESTATED SECURITIES EXCHANGE AGREEMENT This AMENDED AND RESTATED SECURITIES EXCHANGE AGREEMENT (the “Agreement”) is entered into as of July 31, 2024 by and among Viewbix, Inc., a Delaware corporation, with an office address of 3 Hanehoshet St, Building B, 7th floor, Tel Aviv, Israel, 6971068 (“Viewbix”) and Metagramm Software Ltd., an Israeli company, with an office addres |
|
| July 31, 2024 |
Form of First July 2024 Warrant Exhibit 10.14 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 31, 2024 |
Form of July 2024 Common Stock Purchase Warrant Exhibit 10.11 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 31, 2024 |
Form of Second July 2024 Warrant Exhibit 10.19 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 31, 2024 |
Form of June 2024 Facility Warrants Exhibit 10.16 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 31, 2024 (July 31, 2024) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| July 31, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Viewbix Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(4) Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| July 30, 2024 |
Exhibit 10.1 SECURITIES EXCHANGE AGREEMENT This SECURITIES EXCHANGE AGREEMENT (the “Agreement”) is entered into as of July 30, 2024 by and among Viewbix, Inc., a Delaware corporation, with an office address of 3 Hanehoshet St, Building B, 7th floor, Tel Aviv, , Israel, 6971068 (“Viewbix”) and Metagramm Software Ltd., an Israeli company, with an office address 4 Hamelacha St. Netania, Israel (“Meta |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 30, 2024 (July 25, 2024) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| July 30, 2024 |
Exhibit 10.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 30, 2024 |
Exhibit 10.2 SECOND AMENDMENT TO LOAN AGREEMENT This second Amendment (the “Amendment”) to that certain Facility Agreement (“Facility Agreement”) dated July 4, 2024, as amended on July 22, 2024 (the “Effective Date”), by and between Viewbix Inc., a Delaware corporation (the “Borrower”), and Capitalink Ltd., an Israeli limited company (the “Lender”), is entered into effect as of July 25, 2024 (the |
|
| July 30, 2024 |
Exhibit 10.3 FACILITY AGREEMENT This Facility Agreement is made as of July 28, 2024 (the “Agreement Date”) between M.R.M Merhavit Holding and Management Ltd. (the “Lender”), on behalf of itself and on behalf of such lenders set forth in Schedule A, and Viewbix Inc., a Delaware corporation (the “Borrower” or the “Company”) (the Borrower together with the Lender, the “Parties” and individually “Part |
|
| July 30, 2024 |
Viewbix to Acquire 19.99% Stake in AI and Natural Language Processing Grammar Company Exhibit 99.1 Viewbix to Acquire 19.99% Stake in AI and Natural Language Processing Grammar Company Ramat Gan, Israel, July 30, 2024 – Viewbix Inc. (OTC: VBIX) (“Viewbix” or the “Company”), a global developer of mar-tech and ad-tech innovative technologies, today announced it signed a securities exchange agreement to acquire of a 19.99% stake in Metagramm Software Ltd. (“Metagramm”), an innovative |
|
| July 22, 2024 |
Exhibit 10.4 AMENDED AND RESTATED FACILITY AGREEMENT This Amended and Restated Facility Agreement is made as of July [●], 2024 (the “Agreement Date”) between Capitalink Ltd. (the “Lender”) and Viewbix Inc., a Delaware corporation (the “Borrower” or the “Company”) (the Borrower together with the Lender, the “Parties” and individually “Party”), and replaces in its entirety the Facility Agreement ent |
|
| July 22, 2024 |
Form of First Facility Warrants Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 22, 2024 |
Form of Second Facility Warrant Exhibit 10.5 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 22, 2024 |
Exhibit 10.1 AMENDED AND RESTATED FACILITY AGREEMENT This Amended and Restated Facility Agreement is made as of July 17, 2024 (the “Agreement Date”) between such lenders set forth in Schedule 1 (each a “Lender” and collectively the “Lenders”) and Viewbix Inc., a Delaware corporation (the “Borrower” or the “Company”) (the Borrower together with the Lender, the “Parties” and individually “Party”), a |
|
| July 22, 2024 |
Exhibit 10.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 22, 2024 (July 22, 2024) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 15, 2024 VIEWBIX INC. (Exact name of registrant as specified in its charter) Commission File No.: 000-15746 Delaware 68-0080601 (State or other jurisdiction of incorporation) (I. |
|
| July 19, 2024 |
Exhibit 3.1 |
|
| July 5, 2024 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of [], 2024, between Viewbix Inc., a Delaware company (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Purchase Agreement, dated as |
|
| July 5, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 3, 2024, between Viewbix Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions |
|
| July 5, 2024 |
Exhibit 10.5 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 5, 2024 (June 30, 2024) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Em |
|
| July 5, 2024 |
Form of Common Stock Purchase Warrant Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 5, 2024 |
Form of Facility Agreement, dated July 4, 2024 Exhibit 10.4 FACILITY AGREEMENT This Facility Agreement is made as of June 4, 2024 (the “Agreement Date”) between Capitalink Ltd. (the “Lender”) and Viewbix Inc., a Delaware corporation (the “Borrower” or the “Company”) (the Borrower together with the Lender, the “Parties” and individually “Party”). WHEREAS, the Borrower is a corporation quoted on the OTC Market, Pink Tier; WHEREAS, the Borrower d |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☒ Definitive Information Statement VIEWBIX INC. (Name of Registrant as |
|
| June 20, 2024 |
Exhibit 10.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| June 20, 2024 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 20, 2024 (June 18, 2024) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| June 20, 2024 |
Form of Facility Agreement, dated June 18, 2024 Exhibit 10.1 Execution Version FACILITY AGREEMENT This Facility Agreement is made as of June 18, 2024 (the “Agreement Date”) between such lenders set forth in Schedule 1 (each a “Lender” and collectively the “Lenders”) and Viewbix Inc., a Delaware corporation (the “Borrower” or the “Company”) (the Borrower together with the Lender, the “Parties” and individually “Party”). WHEREAS, the Borrower is |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☐ Definitive Information Statement VIEWBIX INC. (Name of Registrant as |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 19, 2024 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identif |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its C |
|
| March 25, 2024 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Emerald Medical Applications Ltd.(2) Israel VB Interactive Video Technologies Inc.(3) Delaware Gix Media Ltd.(4) Israel Cortex Media Group Ltd. (5) Israel (1) Viewbix Ltd. is the wholly-owned subsidiary of Viewbix Inc. (2) Emerald Medical Applications Ltd. is the wholly-owned subsidiary of Viewbix I |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☒ Definitive Information Statement VIEWBIX INC. (Name of Registrant as |
|
| January 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) ☐ Definitive Information Statement VIEWBIX INC. (Name of Registrant as |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 12, 2023 (November 15, 2023) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) ( |
|
| December 12, 2023 |
Exhibit 10.1 LOAN AGREEMENT This Loan Agreement (“Loan Agreement”) is made effective as of November 15, 2023, by and among Viewbix Ltd., a company organized under the laws of the State of Israel (the “Company”), and the lenders set forth in Schedule I hereto (each, a “Lender”, and collectively, the “Lenders”). NOW, THEREFORE, in consideration of the promises and mutual covenants hereinafter contai |
|
| December 12, 2023 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| August 14, 2023 |
Exhibit 99.1 Viewbix Reports its Consolidated Financial Results for the First Half and the Second Quarter of 2023 with Revenues Totaling $48 Million for the First Half of 2023 Ramat Gan, Israel, August 14, 2023 – Viewbix Inc. (OTC: VBIX) (“Viewbix” or the “Company”), a global developer of mar-tech and ad-tech innovative technologies, today announced its consolidated financial results for the first |
|
| August 14, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): August 14, 2023 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identi |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact N |
|
| May 15, 2023 |
Exhibit 99.1 Viewbix Reports its Consolidated Financial Results for the First Quarter of 2023 with Revenues Totaling $20.9 Million Viewbix, together with its subsidiaries, reached EBITDA of $658 thousand Amihay Hadad, Viewbix’s CEO: “We continue to see impressive growth in demand for our digital content platform’s solutions .... With the trend of profit improvement reported in Gix Media’s search p |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact |
|
| May 15, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 15, 2023 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identific |
|
| March 24, 2023 |
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Viewbix Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), shares of common stock, par value $0.0001 (the “Common Stock”). The following is a summary of some of the terms of our Common Stoc |
|
| March 24, 2023 |
Employment Agreement by and between Viewbix Ltd. and Shahar Marom, dated June 28, 2022 Exhibit 10.6 Individual Employment Agreement Made and executed on the 28th day of June, 2022 Between: ViewBix Ltd. Company Reg. No. 513801464 Of 14 Arye Shenkar St., Herzliya (Hereinafter: the “Company”) The first party; And between: Shachar Marom ID. No. 036239325 Of 3 Geulim St., Ramat Gan (Hereinafter: the “Employee”) The second party; Whereas: The Employee offered himself as a candidate for a |
|
| March 24, 2023 |
Exhibit 10.5 Employment Agreement Made and executed in Ramat Gan on the 23th day of February, 2023 Between: ViewBix Ltd., Company Reg. No. 513801464 Of 11 Menachem Begin Rd., Ramat Gan (Hereinafter: the “Company”) The first party; And between: Amihay Hadad, ID. No. 034142505 Of 16/84 HaCarmel St., Rehovot (Hereinafter: the “Manager”) The second party; Whereas: The Manager was employed by GIX INTER |
|
| March 24, 2023 |
Exhibit 10.2 Viewbix Inc. 2023 Stock Incentive Plan Unless otherwise defined, terms used herein shall have the meaning ascribed to them in Section 2 hereof. 1. PURPOSE; TYPES OF AWARDS; CONSTRUCTION. 1.1. Purpose. The purpose of this 2023 Stock Incentive Plan (as amended, this “Plan”) is to afford an incentive to Service Providers of Viewbix Inc., a Delaware corporation (together with any successo |
|
| March 24, 2023 |
Exhibit 99.1 Viewbix Reports its Financial Results for 2022 with a 114% Growth in Revenues Totaling $97 Million Viewbix reached an operating income of $2.7 million Amihay Hadad, Viewbix, CEO: “The acquisition of Cortex and the continued focus on our main activities have been instrumental in driving our growth. In addition to our organic growth, we plan to continue to pursue strategic opportunities |
|
| March 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its C |
|
| March 24, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 24, 2023 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identif |
|
| March 24, 2023 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Emerald Medical Applications Ltd.(2) Israel VB Interactive Video Technologies Inc.(3) Delaware Gix Media Ltd.(4) Israel Cortex Ltd. (5) Israel (1) Viewbix Ltd. is the wholly-owned subsidiary of Viewbix Inc. (2) Emerald Medical Applications Ltd. is the wholly-owned subsidiary of Viewbix Inc. (3) VB I |
|
| March 24, 2023 |
Management Services Agreement by and between Viewbix Ltd. and Yoram Baumann, dated January 12, 2022 Exhibit 10.7 Management Services Agreement Made and executed on the 12th day of January, 2022 Between: ViewBix Ltd. Company Reg. No. 513801464 Of 14 Arye Shenkar St., Herzliya (Hereinafter: the “Company”) The first party; And between: Yoram Baumann ID. No. 051886224 Of 36 HaMazbiim St., Tzahala, Tel Aviv (Hereinafter: “Yoram” or the “Chairman”) The second party; Whereas: The Company desires to rec |
|
| February 14, 2023 |
VBIX / Viewbix Inc / MMCAP International Inc. SPC - FORM SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 23, 2023 |
Exhibit 99.1 Viewbix: Gix Media Increases Holdings in Cortex Media Group to 80% of its Share Capital Viewbix’s CEO: “Our acquisitions in Cortex have allowed us to benefit from the positive trends in Cortex’s content activity, along with Cortex’s excellent financial results and, accordingly, its impact on Viewbix’s financial statements” Ramat Gan, Israel, January 23, 2023 – Viewbix Inc. (OTC: VBIX) |
|
| January 23, 2023 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 23, 2023 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ident |
|
| December 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 27, 2022 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Iden |
|
| November 28, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 28, 2022 (September 19, 2022) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation |
|
| November 28, 2022 |
VIEWBIX INC. COMBINED CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2021 Exhibit 99.1 VIEWBIX INC. COMBINED CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2021 CONTENTS Page Report of Independent Registered Public Accounting Firm (PCAOB ID No. 1197) 2 - 3 Combined Consolidated Balance Sheets 4 - 5 Combined Consolidated Statements of Operations 6 Combined Consolidated Statements of Changes in Shareholders? Equity 7 Combined Consolidated Statements of Cash Flows 8 - 9 No |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-1574 |
|
| November 22, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 22, 2022 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Iden |
|
| November 22, 2022 |
Exhibit 99.1 Viewbix Reports Third Quarter 2022 Financial Results with a 176% Growth in Revenues Totaling $66 Million Viewbix reached an operating income of $1.4 million Amihay Hadad, Viewbix, CEO: ?We entered the field of digital content through a purchase that has proven itself, financially and synergistic and it is our intention to continue pursue opportunities to leverage our growth? Ramat Gan |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For the Period Ended: September 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Rep |
|
| October 6, 2022 |
VBIX / Viewbix Inc / MMCAP International Inc. SPC - NONE Passive Investment SC 13G 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Viewbix Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 926711201 (CUSIP Number) September 19, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| October 3, 2022 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of common stock, par value $0. |
|
| October 3, 2022 |
Exhibit 2 Directors and Executive Officers of Gix Internet Ltd. as of October 3, 2022 The name, position, principal occupation, business address and citizenship of each director and executive officer is set forth below. Name (Citizenship) Position Principal Occupation Business Address Eliyahu Yoresh Chairman of the Board Senior executive 11 Derech Menachem Begin Street, Ramat Gan, Israel Ron Silbe |
|
| October 3, 2022 |
VBIX / Viewbix Inc / Algomizer Ltd Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viewbix Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 926711201 (CUSIP Number) Gix Internet Ltd. (f/k/a Algomizer Ltd.) 11 Derech Menachem Begin Street, Ramat Gan, Israel +972-09-7741505 Name, Address and |
|
| September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 20, 2022 (September 19, 2022) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) |
|
| September 20, 2022 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF Viewbix Inc. (a Delaware corporation) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 3 1.1 REGISTERED OFFICE 3 1.2 OTHER OFFICES 3 ARTICLE II - MEETINGS OF STOCKHOLDERS 3 2.1 PLACE OF MEETINGS 3 2.2 ANNUAL MEETING 3 2.3 SPECIAL MEETING 3 2.4 ADVANCE NOTICE PROCEDURES FOR BUSINESS BROUGHT BEFORE A MEETING 4 2.5 ADVANCE NOTICE PROCEDURES FOR NOMINATIO |
|
| September 6, 2022 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF VIEWBIX INC. Viewbix Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The Corporation was originally incorporated under the name the Infergene Company by the filing of its original Certificate of Incorporation wit |
|
| September 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 6, 2022 (August 31, 2022) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I. |
|
| August 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ☒ Definitive Additional Materials VI |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact N |
|
| June 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 28, 2022 VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identifi |
|
| June 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 14, 2022 (June 13, 2022) VIEWBIX INC. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. E |
|
| June 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ☒ Definitive Additional Materials VI |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact |
|
| March 17, 2022 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Emerald Medical Applications Ltd.(2) Israel Vmedia Merger Sub Ltd.(3) VB Interactive Video Technologies Inc. (4) Israel Delaware (1) Following the consummation of that certain Share Exchange Agreement by and between Virtual Crypto Technologies Inc. and Algomizer Ltd., dated February 7, 2019, Algomiz |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its C |
|
| February 25, 2022 |
DEF 14C 1 formdef14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement VIEWBIX INC |
|
| February 14, 2022 |
PRE 14C 1 formpre14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement VIEWBIX INC |
|
| February 14, 2022 |
VBIX / Viewbix Inc / L.I.A. Pure Capital Ltd - AMENDMENT TO SCHEDULE 13G Passive Investment SC 13G/A 1 ea155542-13ga1liapuviewbix.htm AMENDMENT TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 (Amendment No. 1) VIEWBIX INC. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securities) 926711 102 (CUSIP Number) December 31, 2021 (Date of event which requires filing of this statement) Che |
|
| December 6, 2021 |
Exhibit 10.1 AGREEMENT AND PLAN OF MERGER AGREEMENT AND PLAN OF MERGER (the ?Agreement?), dated as of December 5, 2021, by and among Gix Media Ltd. (formerly known as Linkury Ltd.), an Israeli company (the ?Gix Media?), Viewbix Inc., a Delaware corporation (?Viewbix Parent?) and Vmedia Merger Sub Ltd., an Israeli company and a wholly-owned subsidiary of Viewbix Parent (?Merger Sub?). Gix Media, Vi |
|
| December 6, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 6, 2021 Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ident |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exact N |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| March 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identification No.) 14 |
|
| March 16, 2021 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Emerald Medical Applications Ltd.(2) Israel (1) Following the consummation of that certain Share Exchange Agreement by and between Virtual Crypto Technologies Inc. and Algomizer Ltd., dated February 7, 2019, Algomizer Ltd. assigned, transferred and delivered 99.83% of Viewbix Ltd. to Virtual Crypto |
|
| February 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 VIEWBIX INC. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securities) 926711 102 (CUSIP Number) December 18, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
| December 21, 2020 |
Exhibit 10.1 STOCK SUBSCRIPTION AGREEMENT THIS STOCK SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into effective December 18, 2020, by and among Viewbix Inc., a Delaware corporation (the “Company”), and the persons and/or entities set forth in Schedule I hereto (each a “Subscriber”, and collectively the “Subscribers”). Pursuant to the terms and conditions of this Agreement, Compan |
|
| December 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 21, 2020 Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Iden |
|
| December 21, 2020 |
Exhibit 10.2 LOAN AGREEMENT This Loan Agreement (“Loan Agreement”) is made effective as of December 18, 2020, by and among Viewbix Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and the lenders set forth in Schedule I hereto (each, a “Lender”, and collectively, the “Lenders”). NOW, THEREFORE, in consideration of the promises and mutual covenants hereinafter c |
|
| November 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. |
|
| August 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exa |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Ex |
|
| March 20, 2020 |
Subsidiaries of the Registrant Exhibit 21.1 LIST OF SUBSIDIARIES Company Name Jurisdiction of Incorporation Viewbix Ltd.(1) Israel Virtual Crypto Technologies Ltd. (2) Israel VB Interactive Video Technologies Inc. (3) Delaware Emerald Medical Applications Ltd.(4) Israel (1) Following the consummation of that certain Share Exchange Agreement by and between Virtual Crypto Technologies Inc. and Algomizer Ltd., dated February 7, 20 |
|
| March 20, 2020 |
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Viewbix Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our shares of common stock, par value $0.0001 (the “Common Stock”). The following is a summary of some of the terms of our Common |
|
| March 20, 2020 |
VBIX / ViewBix Inc. 10-K - Annual Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Commission file number 000-15746 VIEWBIX INC. (Exact Name of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Identification No.) 14 |
|
| February 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 24, 2020 (February 20, 2020) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) ( |
|
| February 6, 2020 |
Resignation Letter of Mr. Noam Band, dated February 3, 2020 Exhibit 17.1 From: Noam Band Date: Monday, February 3, 2020, 8:25 a.m. Subject: Board resignation To: Amihay Hadad , [email protected] Guys, Please accept this email as my resignation from the Viewbix board effective immediately. - /s/ Noam Band +972-54-2288897 |
|
| February 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 6, 2020 (February 3, 2020) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I. |
|
| January 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 2, 2020 (January 1, 2020) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R. |
|
| January 2, 2020 |
Resignation Letter of Mr. Jonathan Stefansky, dated January 1, 2020 January 1, 2020 To: Viewbix Inc. Chairman of the Board, Mr. Noam Band Dear Noam, Please accept this letter as my resignation from the Viewbix board effective immediately. Thanks, /s/ Jonathan Stefansky Mr. Jonathan Stefansky |
|
| November 13, 2019 |
VRCP / Virtual Crypto Technologies Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. |
|
| November 12, 2019 |
Letter from Halperin CPA, Financial Consulting & Management, dated November 12, 2019 Exhibit 16.1 November 12, 2019 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Viewbix Inc. under Item 4.01 of its Form 8-K dated and filed on November 12, 2019. We agree with the statements concerning our Firm in such Form 8-K. We agree with the statements concerning the dismissal of our Firm in such Form 8-K. Very trul |
|
| November 12, 2019 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 12, 2019 Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Iden |
|
| September 23, 2019 |
VIEWBIX LTD. AND ITS SUBSIDIARY UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2019 VIEWBIX LTD. AND ITS SUBSIDIARY UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2019 CONTENTS Page Interim Consolidated Balance Sheets for the and Six Months ended June 30, 2019 and Year Ended December 31, 2018 (Unaudited) 3 - 4 Interim Consolidated Statements of Comprehensive Loss for the Three and Six |
|
| September 23, 2019 |
VIEWBIX LTD. AND ITS SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2018 and 2017 VIEWBIX LTD. AND ITS SUBSIDIARY CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2018 and 2017 CONTENTS Page Report of Independent Registered Public Accounting Firm 2 Consolidated Balance Sheets 3-4 Consolidated Statements of Comprehensive Loss 5 Consolidated Statements of Changes in Temporary Equity and Sha |
|
| September 23, 2019 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 23, 2019 (July 25, 2019) Viewbix Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I |
|
| September 23, 2019 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS The following unaudited pro forma condensed combined financial statements were prepared using the acquisition method of accounting under U. |
|
| August 14, 2019 |
VRCP / Virtual Crypto Technologies Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIEWBIX INC. (Exa |
|
| August 13, 2019 |
VBIX / ViewBix Inc. CORRESP - - August 13, 2019 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| August 13, 2019 |
VRCP / Virtual Crypto Technologies Inc. / Algomizer Ltd Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Viewbix Inc. (Name of Issuer) Shares of Common Stock, par value $0.0001 per share (Title of Class of Securities) 926711 102 (CUSIP Number) Algomizer Ltd. 14 Shenkar Arie, Herzliya, Israel Tel: +972-9-7741505 Fax: +972-9-7741534 Name, Address and Telephone |
|
| August 13, 2019 |
Directors and Executive Officers of Algomizer Ltd. as of August 13, 2019 The name, position, principal occupation, business address and citizenship of each director and executive officer is set forth below. Name (Citizenship) Position Principal Occupation Business Address Noam Band (Israel) Chairman of the Board of Directors Chairman of the Board of Directors of Viewbix Inc.; Chief Executive Offic |
|
| July 25, 2019 |
VRCP / Virtual Crypto Technologies Inc. SC 14F1 - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 Promulgated Thereunder Date of Information Statement: July 25, 2019 Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (St |
|
| July 25, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 25, 2019 Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R |
|
| July 25, 2019 |
FIRST AMENDMENT TO SHARE EXCHANGE AGREEMENT This First Amendment to the Share Exchange Agreement, dated as of July 24, 2019 (this “First Amendment”), is entered into by and among Algomizer Ltd. |
|
| July 25, 2019 |
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| July 25, 2019 | ||
| May 15, 2019 |
Exhibit 3.4 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION Emerald Medical Applications Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of Emerald Medical Applications Corp. (the “Corporation”) resolutions were duly adopted sett |
|
| May 15, 2019 |
VRCP / Virtual Crypto Technologies Inc. 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIRTUAL CRYPTO T |
|
| May 15, 2019 |
Services Agreement, dated as of February 15, 2018, between the Company and Yair Fudim. |
|
| April 4, 2019 |
VRCP / Virtual Crypto Technologies Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement VIRTUAL CRYPTO TECHNOLOGIES, I |
|
| March 29, 2019 |
VRCP / Virtual Crypto Technologies Inc. (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number 0-15746 VIRTUAL CRYPTO TECHNOLOGIES, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ide |
|
| March 25, 2019 |
VRCP / Virtual Crypto Technologies Inc. CORRESP CORRESP 1 filename1.htm March 25, 2019 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mara Ransom Re: Virtual Crypto Technologies, Inc. Preliminary Information Statement on Schedule 14C Filed February 26, 2019 File No. 000-15746 Dear Ms. Ransom: This letter sets forth the response of Virtual Crypto Technol |
|
| February 26, 2019 |
VRCP / Virtual Crypto Technologies Inc. PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement VIRTUAL CRYPTO TECHNOLOGIES, I |
|
| February 7, 2019 |
Exhibit 10.1 SHARE EXCHANGE AGREEMENT This SHARE EXCHANGE AGREEMENT (the “Agreement”) is entered into as of February 7, 2019 by and among Algomizer Ltd., an Israeli Corporation (“Algomizer”) and Virtual Crypto Technologies Inc., a Delaware corporation (“VCT”). Algomizer and VCT, each a “Party” and collectively, the “Parties”. WHEREAS, Algomizer owns 99.83% of the issued and outstanding share capit |
|
| February 7, 2019 |
Entry into a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 7, 2019 (February 5, 2019) Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State |
|
| November 13, 2018 |
VRCP / Virtual Crypto Technologies Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIRTUAL CRYP |
|
| August 14, 2018 |
VRCP / Virtual Crypto Technologies Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIRTUAL CRYPTO TE |
|
| July 31, 2018 |
VRCP / Virtual Crypto Technologies Inc. 10-Q/A (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) [ ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15 |
|
| July 25, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 25, 2018 Virtual Crypto Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 000-15746 68-0080601 (State or other jurisdiction of incorporation) (Co |
|
| July 25, 2018 |
Exhibit 99.1 Virtual Crypto Technologies well-positioned as SEC public comments show favor towards cryptocurrencies US securities regulator sending positive signals as the market anticipates Bitcoin ETF Rosh Haa’yin, Israel – July 25, 2018 - Virtual Crypto Technologies, Inc. (OTCQB: VRCP) (“Virtual Crypto”), a developer of software and hardware for the purchase and sale of crypto-currencies throug |
|
| July 10, 2018 |
Exhibit 16.1 July 10, 2018 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F. Street, NE Washington, DC 20549 RE: Virtual Crypto Technologies, Inc. Ladies and Gentlemen: We have read Item 4.01 of Virtual Crypto Technologies, Inc.’s Form 8-K dated July 6, 2018, and have the following comments: 1. We agree with the statement that our audit reports on the financial statemen |
|
| July 10, 2018 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 6, 2018 Virtual Crypto Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 000-15746 68-0080601 (State or other jurisdiction of incorporation) (Com |
|
| July 6, 2018 |
Letter of Resignation of Yair Fudim dated June 30, 2018 (filed herewith). EXHIBIT 17.1 Letter of Resignation June 30, 2018 Board of Directors Virtual Crypto Technologies, Inc. Re: Letter of Resignation Gentlemen: I hereby resign as CEO and Chairman of the Board of Directors of Virtual Crypto Technologies, Inc. (the “Registrant”), effective June 30, 2018. The reason for my resignation is to permit me to pursue other business interests and opportunities. I have had no dis |
|
| July 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2018 Virtual Crypto Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 000-15746 Delaware 68-0080601 (State of or other jurisdi |
|
| May 22, 2018 |
VRCP / Virtual Crypto Technologies Inc. 10-Q/A (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) [ ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15 |
|
| May 21, 2018 |
EX-10.20 3 ex10-20.htm |
|
| May 21, 2018 |
VRCP / Virtual Crypto Technologies Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-15746 VIRTUAL CRYPTO T |
|
| May 21, 2018 |
Exhibit 3.4 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION Emerald Medical Applications Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of Emerald Medical Applications Corp. (the “Corporation”) resolutions were duly adopted sett |
|
| May 15, 2018 |
VRCP / Virtual Crypto Technologies Inc. NT 10-Q NT 10-Q 1 nt10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Virtual Crypto Technologies, Inc (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10Q [ ] Form N-SAR [ ] For Period Ended: March 31, 2018 [ ] Transition Report on Form 10-K [ ] Transition Report on F |
|
| April 17, 2018 |
EXHIBIT 99.1 Virtual Crypto Technologies, Inc. 2017 Employee Incentive Plan SECTION 1. INTRODUCTION 1.1 Establishment. Effective as provided in Section 17, Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp., a Delaware corporation (the “Company”), hereby establishes this plan of stock-based compensation for selected Eligible Participants of the Company. This Plan shall be |
|
| April 17, 2018 |
MRLA / Emerald Medical Applications Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 Commission file number 0-15476 VIRTUAL CRYPTO TECHNOLOGIES, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employer Ide |
|
| March 29, 2018 |
MRLA / Emerald Medical Applications Corp. LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 VIRTUAL CRYPTO TECHNOLOGIES, INC. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [X]Form 10-K [ ] Form 20-F [ ]Form 11-K [ Form 10Q [ ] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form |
|
| March 21, 2018 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 16, 2018 Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State or other jurisdict |
|
| March 16, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 14, 2018 Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I. |
|
| March 12, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 8, 2018 Virtual Crypto Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) (I.R |
|
| February 16, 2018 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 13, 2018 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) |
|
| February 15, 2018 |
Exhibit 17.10 Letter of Resignation Dated: February 14, 2018 Board of Directors Emerald Medical Applications Corp. Re: Letter of Resignation I hereby resign as a CEO and Chairman of Emerald Medical Applications Corp. (the "Registrant") effective February 14, 2018. The reason for my resignation is to permit me to pursue other business interests and opportunities. I have had no disagreements with th |
|
| February 15, 2018 |
8-K 1 mrla8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 14, 2018 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-00 |
|
| February 12, 2018 |
MRLA / Emerald Medical Applications Corp. 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement EMERALD MEDICAL APPLICATIONS C |
|
| February 1, 2018 |
MRLA / Emerald Medical Applications Corp. 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement EMERALD MEDICAL APPLICATIONS C |
|
| January 24, 2018 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 23, 2018 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I |
|
| January 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 18, 2018 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 000-15746 Delaware 68-0080601 (State of Incorporation) |
|
| January 19, 2018 |
Letter of Resignation of Estery Giloz-Ran dated January 16, 2018, filed herewith. EXHIBIT 17.8 Letter of Resignation Dated: January 16, 2018 Board of Directors Emerald Medical Applications Corp. Re: Letter of Resignation I hereby resign as a director of Emerald Medical Applications Corp. (the ?Registrant?) effective January 18, 2018. The reason for my resignation is to permit me to pursue other business interests. I have had no disagreements with the operations, policies or pra |
|
| January 19, 2018 |
Letter of Resignation of Ascher Shmulewitz dated January 16, 2018, filed herewith. EXHIBIT 17.9 Letter of Resignation Dated: January 16, 2018 Board of Directors Emerald Medical Applications Corp. Re: Letter of Resignation I hereby resign as a director of Emerald Medical Applications Corp. (the ?Registrant?) effective January 18, 2018. The reason for my resignation is to permit me to pursue other business interests. I have had no disagreements with the operations, policies or pra |
|
| December 29, 2017 |
MRLA / Emerald Medical Applications Corp. 10-Q (Quarterly Report) 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 Commission file number: 000-15476 Emerald Medical Applications Corp (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Inc |
|
| November 14, 2017 |
MRLA / Emerald Medical Applications Corp. LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 EMERALD MEDICAL APPLICATIONS CORP. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [ ]Form 10-K [ ] Form 20-F [ ]Form 11-K [X] Form 10Q [ ] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| October 23, 2017 |
Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): October 23, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I |
|
| August 31, 2017 |
EXHIBIT 10.40 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| August 31, 2017 |
EXHIBIT 10.42 Certificate Of Designation Of The Relative Rights And Preferences Of The Series A Convertible Preferred Stock Of Emerald Medical Applications Corp. The undersigned, representing all of the members of the Board of Directors of Emerald Medical Applications Corp., a Delaware corporation (the "Company"), in accordance with the provisions of Title 8, Section 151, of the Delaware General C |
|
| August 31, 2017 |
EXHIBIT 10.37 SUPREME COURT OF THE STATE OF NEW YORK COUNTY OF NEW YORK - ALPHA CAPITAL ANSTALT and CHI SQUARED CAPITAL, INC. Plaintiffs, v. SETTLEMENT EMERALD MEDICAL APPLICATIONS CORP., Index No.: Defendant. - This Settlement Agreement (this "Agreement"), is made and entered this 7th day of August 2017 between Alpha Capital Anstalt ("Alpha") and Chi Squared Capital, Inc. ("Chi Squared" and toget |
|
| August 31, 2017 |
EXHIBIT 10.38 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGI |
|
| August 31, 2017 |
EXHIBIT 10.39 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGI |
|
| August 31, 2017 |
EXHIBIT 10.41 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| August 31, 2017 |
Emerald Medical Applications CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): August 7, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I.R |
|
| August 24, 2017 |
MRLA / Emerald Medical Applications Corp. 10-Q/A (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No: 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission file number: 0-15476 Emerald Medical Applications Corp (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporatio |
|
| August 23, 2017 |
MRLA / Emerald Medical Applications Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission file number: 0-15476 Emerald Medical Applications Corp (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employe |
|
| August 14, 2017 |
Emerald Medical Applications LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 EMERALD MEDICAL APPLICATIONS CORP. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [ ]Form 10-K [ ] Form 20-F [ ]Form 11-K [X] Form 10Q [ ] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| May 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 15, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I.R |
|
| May 22, 2017 |
Emerald Medical Applications FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2017 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Commission file number: 0-15476 Emerald Medical Applications Corp. (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Employe |
|
| May 15, 2017 |
Emerald Medical Applications LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 EMERALD MEDICAL APPLICATIONS CORP. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [ ]Form 10-K [ ] Form 20-F [ ]Form 11-K [X] Form 10Q [ ] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| April 27, 2017 |
Exhibit 17.8 David Ben Naim Letter of Resignation April 18, 2017 Emerald Medical Application Corp. Attention: Board of Directors Ladies and Gentlemen: Please accept my resignation as Chief Financial Officer of Emerald Medical Applications Corp. and its wholly-owned Israeli subsidiary, Emerald Medical Applications Ltd., effective immediately. The reason for my resignation is to permit me to pursue |
|
| April 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 18, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I.R |
|
| April 18, 2017 |
10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Commission file number 0-15476 EMERALD MEDICAL APPLICATIONS CORP. (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) |
|
| April 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 4, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I. |
|
| April 7, 2017 |
Adi Zamir Letter of Resignation EXHIBIT 17.7 Adi Zamir Letter of Resignation March 26, 2017 Board of Directors Emerald Medical Applications Corp. Attention: Yair Fudim, Chairman Please accept this letter as notice under my employment agreement that effective June 23, 2017 (the "Effective Date"), I will cease serving Chief Executive Officer of Emerald Medical Applications Corp. (the "Registrant") and its wholly-owned Israeli subs |
|
| April 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 4, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I.R. |
|
| April 7, 2017 |
Adi Zamir Letter of Resignation EXHIBIT 17.7 Adi Zamir Letter of Resignation March 26, 2017 Board of Directors Emerald Medical Applications Corp. Attention: Yair Fudim, Chairman Please accept this letter as notice under my employment agreement that effective June 23, 2017 (the "Effective Date"), I will cease serving Chief Executive Officer of Emerald Medical Applications Corp. (the "Registrant") and its wholly-owned Israeli subs |
|
| March 31, 2017 |
Emerald Medical Applications LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 EMERALD MEDICAL APPLICATIONS CORP. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [X]Form 10-K [ ] Form 20-F [ ]Form 11-K [ ] Form 10Q [ ] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| February 27, 2017 |
Exhibit 99.1 IRIS Capital Management Purchases Approximately 6% of the common shares of Emerald Medical Applications at $.40 per Share Purchase resulted from Emerald Medical Applications winning The Grand Prize at Publicis Groupe "Publicis 90" Initiative Emerald Medical Applications Corp. (OTCQB: MRLA) Petach Tikva, Israel February 27, 2017 On February 27, 2017, Emerald Medical Applications Corp. |
|
| February 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 17, 2017 Emerald Medical Applications Corp. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) ( |
|
| January 26, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 26, 2017 EMERALD MEDICAL APPLICATIONS CORP. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) (I |
|
| December 30, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 25, 2016 EMERALD MEDICAL APPLICATIONS CORP. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) ( |
|
| December 30, 2016 |
xhibit 17.6 Chaim Hurvitz December 25, 2016 Emerald Medical Applications Corp. Attention: Board of Directors To all members of the Board of Director: I would like to submit my resignation as a director of the company, effective immediately. Sincerely, Chaim Hurvitz |
|
| December 30, 2016 |
Exhibit 17.5 Baruch Kfir December 25, 2016 Emerald Medical Applications Corp. Attention: Board of Directors Ladies and Gentlemen: I would like to submit my resignation as a member of the Board of Directors, effective immediately. The reason for my resignation is for personal reasons. Sincerely, Baruch Kfir |
|
| December 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 18, 2016 EMERALD MEDICAL APPLICATIONS CORP. (Exact Name of Registrant as Specified in its Charter) Commission File No.: 0-15476 Delaware 68-0080601 (State of Incorporation) ( |
|
| November 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Commission file number: 0-15476 EMERALD MEDICAL APPLICATIONS CORP. (Exact Name Of Registrant As Specified In Its Charter) Delaware 68-0080601 (State of Incorporation) (I.R.S. Emp |
|
| November 14, 2016 |
Emerald Medical Applications LATE NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 EMERALD APPLICATIONS CORP. (Full Name of Registrant) FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: [0-15476] (Check One): [ ]Form 10-K [ ] Form 20-F [ ]Form 11-K [ ] Form 10Q [X] Form N-SAR [ ] For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K |
